These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 33581409)

  • 1. Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen-Defined Pancreatic Cancer Tissues.
    McDowell CT; Klamer Z; Hall J; West CA; Wisniewski L; Powers TW; Angel PM; Mehta AS; Lewin DN; Haab BB; Drake RR
    Mol Cell Proteomics; 2021; 20():100012. PubMed ID: 33581409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative structural analysis of glycans expressed within tumors derived from pancreatic cancer patient-derived xenograft mouse models.
    Hasehira K; Furuta T; Shimomura O; Asada M; Oda T; Tateno H
    Biochem Biophys Res Commun; 2021 Jan; 534():310-316. PubMed ID: 33288196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells.
    Barnett D; Liu Y; Partyka K; Huang Y; Tang H; Hostetter G; Brand RE; Singhi AD; Drake RR; Haab BB
    Sci Rep; 2017 Jun; 7(1):4020. PubMed ID: 28642461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Systems Analysis of the Murine and Human Pancreatic Cancer Glycomes Reveals a Tumor-Promoting Role for ST6GAL1.
    Kurz E; Chen S; Vucic E; Baptiste G; Loomis C; Agrawal P; Hajdu C; Bar-Sagi D; Mahal LK
    Mol Cell Proteomics; 2021; 20():100160. PubMed ID: 34634466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivariate data analysis for the detection of human alpha-acid glycoprotein aberrant glycosylation in pancreatic ductal adenocarcinoma.
    Mancera-Arteu M; Giménez E; Balmaña M; Barrabés S; Albiol-Quer M; Fort E; Peracaula R; Sanz-Nebot V
    J Proteomics; 2019 Mar; 195():76-87. PubMed ID: 30641231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis.
    Staal B; Liu Y; Barnett D; Hsueh P; He Z; Gao C; Partyka K; Hurd MW; Singhi AD; Drake RR; Huang Y; Maitra A; Brand RE; Haab BB
    Clin Cancer Res; 2019 May; 25(9):2745-2754. PubMed ID: 30617132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialylated N-glycans in adult rat brain tissue--a widespread distribution of disialylated antennae in complex and hybrid structures.
    Zamze S; Harvey DJ; Chen YJ; Guile GR; Dwek RA; Wing DR
    Eur J Biochem; 1998 Nov; 258(1):243-70. PubMed ID: 9851715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individuals.
    Levink IJM; Klatte DCF; Hanna-Sawires RG; Vreeker GCM; Ibrahim IS; van der Burgt YEM; Overbeek KA; Koopmann BDM; Cahen DL; Fuhler GM; Wuhrer M; Bonsing BA; Tollenaar RAEM; Vleggaar FP; Vasen HFA; van Leerdam ME; Bruno MJ; Mesker WE
    Pancreatology; 2022 May; 22(4):497-506. PubMed ID: 35414481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. rBC2LCN-reactive SERPINA3 is a glycobiomarker candidate for pancreatic ductal adenocarcinoma.
    Mawaribuchi S; Shimomura O; Oda T; Hiemori K; Shimizu K; Yamase K; Date M; Tateno H
    Glycobiology; 2023 May; 33(4):342-352. PubMed ID: 36728830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell lines.
    Bassagañas S; Allende H; Cobler L; Ortiz MR; Llop E; de Bolós C; Peracaula R
    Cytokine; 2015 Sep; 75(1):197-206. PubMed ID: 25934648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the human kidney N-glycome in normal and cancer tissues using MALDI imaging mass spectrometry.
    Drake RR; McDowell C; West C; David F; Powers TW; Nowling T; Bruner E; Mehta AS; Angel PM; Marlow LA; Tun HW; Copland JA
    J Mass Spectrom; 2020 Apr; 55(4):e4490. PubMed ID: 31860772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant fungal lectin for labeling truncated glycans on human cancer cells.
    Audfray A; Beldjoudi M; Breiman A; Hurbin A; Boos I; Unverzagt C; Bouras M; Lantuejoul S; Coll JL; Varrot A; Le Pendu J; Busser B; Imberty A
    PLoS One; 2015; 10(6):e0128190. PubMed ID: 26042789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
    Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
    Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry.
    Shi C; Merchant N; Newsome G; Goldenberg DM; Gold DV
    Arch Pathol Lab Med; 2014 Feb; 138(2):220-8. PubMed ID: 24476519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of glycans containing 3' fucose in a subset of pancreatic cancers uncovered using fusion-tagged lectins.
    Singh S; Pal K; Yadav J; Tang H; Partyka K; Kletter D; Hsueh P; Ensink E; Kc B; Hostetter G; Xu HE; Bern M; Smith DF; Mehta AS; Brand R; Melcher K; Haab BB
    J Proteome Res; 2015 Jun; 14(6):2594-605. PubMed ID: 25938165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen as a specific glycoprotein ligand of rBC2LCN lectin on pancreatic ductal adenocarcinoma cells.
    Furuta T; Oda T; Kiyoi K; Yusuke O; Kimura S; Kurimori K; Miyazaki Y; Yu Y; Furuya K; Akashi Y; Shimomura O; Tateno H
    Cancer Sci; 2021 Sep; 112(9):3722-3731. PubMed ID: 34115906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum N-Glycome analysis reveals pancreatic cancer disease signatures.
    Vreeker GCM; Hanna-Sawires RG; Mohammed Y; Bladergroen MR; Nicolardi S; Dotz V; Nouta J; Bonsing BA; Mesker WE; van der Burgt YEM; Wuhrer M; Tollenaar RAEM
    Cancer Med; 2020 Nov; 9(22):8519-8529. PubMed ID: 32898301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9 alone.
    Haab B; Qian L; Staal B; Jain M; Fahrmann J; Worthington C; Prosser D; Velokokhatnaya L; Lopez C; Tang R; Hurd MW; Natarajan G; Kumar S; Smith L; Hanash S; Batra SK; Maitra A; Lokshin A; Huang Y; Brand RE
    Cancer Lett; 2024 Nov; 604():217245. PubMed ID: 39276915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of aberrantly expressed glycans in gastric cancer by integrated lectin microarray and mass spectrometric analyses.
    Li X; Guan F; Li D; Tan Z; Yang G; Wu Y; Huang Z
    Oncotarget; 2016 Dec; 7(52):87284-87300. PubMed ID: 27895315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of tumor cell sialylation in pancreatic cancer progression.
    Marciel MP; Haldar B; Hwang J; Bhalerao N; Bellis SL
    Adv Cancer Res; 2023; 157():123-155. PubMed ID: 36725107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.